| 1 | AAV directed hLDLR gene therapy | - | - | - | - | 1件: 79 79 |
| 2 | AAV2-GDNF gene therapy | - | - | - | - | 1件: 17 17 |
| 3 | AB-1001 Gene Therapy | - | - | - | - | 1件: 8 8 |
| 4 | Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV) | 1件: Adenosine Adenosine | 1件: D00045
D00045
| 4件: ADORA1 ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 | 12件: Alcoholism Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 |
| 5 | Gene therapy | - | - | - | - | 1件: 65 65 |
| 6 | Gene Therapy Method for CGD | - | - | - | - | 1件: 65 65 |
| 7 | Gene Therapy product:vMCO-I | - | - | - | - | 1件: 90 90 |
| 8 | Gene Therapy-vMCO-010 | - | - | - | - | 1件: 301 301 |
| 9 | Intracerebral LV gene therapy | - | - | - | - | 1件: 20 20 |
| 10 | Lymphocyte gene therapy | - | - | - | - | 1件: 19 19 |
| 11 | OTL-200 Gene Therapy | - | - | - | - | 1件: 19 19 |
| 12 | Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy | - | - | - | - | 1件: 79 79 |
| 13 | TgAAC94 gene therapy vector | - | - | - | - | 2件: 46 46, 271 |
| 14 | X vivo gene therapy | - | - | - | - | 1件: 65 65 |